CRISPR Therapeutics

Company Snapshot
Baarerstrasse 14
Zug, 6300
Switzerland
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 93
http://www.crisprtx.com
Please select from the dropdown
  1. Executive Compensation
  2. > CRISPR Therapeutics
Company Financials

2022
2023
2024
Gross Profit
-$109,814,000
$239,750,000
-$75,250,000
Operating Income
-$673,161,000
-$222,538,000
-$466,566,000
Net Income
-$650,175,000
-$153,610,000
-$366,252,000
2022
Gross Profit
-$109,814,000
Operating Income
-$673,161,000
Net Income
-$650,175,000
2023
Gross Profit
$239,750,000
Operating Income
-$222,538,000
Net Income
-$153,610,000
2024
Gross Profit
-$75,250,000
Operating Income
-$466,566,000
Net Income
-$366,252,000
The above data on CRISPR Therapeutics came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Raju Prasad
Chief Financial Officer and Principal Accounting Officer
$675,876
$5,030,406
$12,284
$5,718,566
Raju Prasad
$5,718,566
Chief Financial Officer and Principal Accounting Officer
James Kasinger
General Counsel and Secretary
$721,524
$2,775,674
$13,200
$3,510,398
James Kasinger
$3,510,398
General Counsel and Secretary
Douglas Treco
Lead Independent Director
$70,000
$482,560
$0
$552,560
Douglas Treco
$552,560
Lead Independent Director
Simeon George
Independent Director
$60,000
$482,560
$0
$542,560
Simeon George
$542,560
Independent Director
H. Fleming
Independent Director
$53,681
$482,560
$0
$536,241
H. Fleming
$536,241
Independent Director
CRISPR Therapeutics listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2023. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us